The Synthetic Ep 4 Beta By Carbon Link -
Incubation with human liver microsomes shows a half-life exceeding 8 hours, compared to 15 minutes for PGE2. The carbon link is impervious to esterase cleavage, and the beta hydroxyl resists 15-hydroxyprostaglandin dehydrogenase (15-PGDH) oxidation—the primary inactivation pathway for natural prostaglandins.
In the realm of medicinal chemistry, few molecular frameworks have proven as versatile as the prostaglandin scaffold. For decades, researchers have sought to modify these naturally occurring lipid compounds to achieve receptor selectivity, metabolic stability, and improved pharmacokinetic profiles. Among the most intriguing recent developments is the synthetic EP 4 beta by carbon link—a novel analog that is reshaping our understanding of EP4 receptor agonism and antagonism.
While the "beta" designation and "carbon link" specification might seem technical, they represent critical structural deviations from native prostaglandin E2 (PGE2). This article explores the chemistry, pharmacology, and clinical potential of this synthetic entity, providing a comprehensive resource for medicinal chemists and pharmacologists.
EP4 has dual roles in colitis. Acute activation protects the mucosal barrier, but chronic activation promotes fibrosis. The selective, context-dependent action of the synthetic beta analog allows for tailored therapy. Animal studies show reduced disease activity index and preserved epithelial integrity. the synthetic ep 4 beta by carbon link
| Feature | Benefit | |---------|---------| | Metabolic resistance | Carbon-carbon bonds are not easily cleaved by esterases or cytochrome P450 enzymes, extending half-life. | | Conformational constraint | Locks the molecule in an active conformation for EP4, reducing off-target binding. | | Improved pharmacokinetics | Enhanced stability allows for oral bioavailability and longer duration of action. | | Simplified synthesis | Carbon link chemistry (e.g., olefin metathesis, cross-coupling) is robust and scalable. |
| Action | Contact / Method |
|--------|------------------|
| Request a quote for re-synthesis | Email Carbon Link’s custom synthesis team: info@carbonlink.com (verify current contact via their website). Provide the original PO or internal code “EP4 Beta.” |
| Request Certificate of Analysis (CoA) | If previously synthesized, Carbon Link retains batch records. Provide batch number or synthesis date. |
| Design a similar EP4-linker conjugate | Use Carbon Link’s linker selection guide (PEG2-PEG24, alkane, disulfide, or cleavable). Specify “EP4 antagonist derivative with beta-alanine spacer.” |
The term “Synthetic EP 4 Beta” does not appear as a standard, off-the-shelf catalog item from Carbon Link (a company specializing in bioconjugation, PEGylation, and specialty organic synthesis). Instead, it is highly likely a custom synthesis project designation or an internal research code. Incubation with human liver microsomes shows a half-life
Based on chemical nomenclature:
Thus, “Synthetic EP 4 Beta by Carbon Link” most likely means: A custom-synthesized EP4-targeting ligand or drug analog, conjugated via a beta-substituted linker, manufactured by Carbon Link under a contract research agreement.
The EP4 receptor is one of four known receptors (EP1-EP4) for the endogenous lipid mediator Prostaglandin E2. It is a G-protein-coupled receptor (GPCR) primarily coupled to the Gs protein, leading to increased intracellular cyclic AMP (cAMP). EP4 plays critical roles in: Thus, “Synthetic EP 4 Beta by Carbon Link”
Studying EP4 has been challenging due to the existence of multiple EP receptor subtypes with overlapping ligand specificities. Natural PGE2 binds to all four EP receptors with high affinity, making it difficult to isolate EP4-specific effects.
In natural PGE2, the hydroxyl group at the C-9 position is in the alpha (α) orientation (below the ring plane). In the synthetic EP4 beta analog, this hydroxyl is inverted to the beta (β) configuration (above the ring plane). This seemingly minor change dramatically alters receptor binding affinity and functional selectivity.